SEC Tracker
Get the app
PEN · XBRL financial data

Penumbra financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (PEN's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue285279299301316*324339355385*375390410
Revenue from contracts with customers—279299301—324339355—375390410
Cost of revenue9898137101105*108115114123*121125130
Gross profit187181163200211*216224240262*253265280
Selling, general and administrative130*144142140148*153160169181*193199204
Total operating expenses152169244165168*176183192203*215224230
Operating income (loss)35*12(81)3543*40414959*384151
Interest income3*3433*3445*566
Interest expense0*0000*0000*000
Other income (expense)1*(0)(0)1(1)*01(1)0*(1)(0)(0)
Income tax expense (benefit)(16)4(18)1011*50616*91114
Net income (loss)5411(60)3034*39454647*333542
Earnings per share, basic USD per share1.400.28(1.55)0.760.88*1.021.171.171.21*0.830.881.07
Earnings per share, diluted USD per share1.380.28(1.55)0.750.85*1.001.151.171.20*0.820.881.07
Weighted average shares, basic millions of shares3939393938*39393939*393939
Weighted average shares, diluted millions of shares3939393940*39393939*404040

Balance sheet

CSV

Fiscal quarters (PEN's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents167223288280324376422321187241205254
Marketable securities1229051111633149358374454419
Accounts receivable202192201176168168176183190183190195
Inventory388398374393407416428432432439443459
Prepaid and other current assets363129313737385550385249
Total current assets9159359448929511,0001,0651,1421,2171,2751,3441,377
Property and equipment, net7376586063728598117134147156
Right-of-use asset189186183181178175174171174170167164
Goodwill166166166166166166167167167167167166
Total assets1,5561,5801,5351,4791,5331,5931,6751,7441,8271,8981,9752,025
Accounts payable273233333131283035444542
Accrued liabilities111107104106112113114124132152172175
Total current liabilities151153151153158159158170183212234234
Lease liability, non-current197195192190187185183180183179176173
Total liabilities377376373375382380381386399425444442
Retained earnings13514686266099144190238270305347
Total stockholders' equity1,1791,2041,1611,1041,1511,2131,2941,3591,4281,4741,5311,584
Total liabilities and equity1,5561,5801,5351,4791,5331,5931,6751,7441,8271,8981,9752,025
Common shares outstanding (cover page) millions of shares393939383939393939393939

Cash flows

CSV

Fiscal quarters (PEN's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)5411(60)3034*39454647*333542
Stock-based compensation11*1410*11*12*1414*16*15*1514*15*
Depreciation and amortization7*88*4*4*56*2*4*56*5*
Net cash from operating activities36*3823*56*51*4945*58*86*8746*42*
Purchases of property and equipment4*65*5*5*1316*16*18*1414*15*
Net cash from investing activities24*1834*36*(11)*(1)(16)*(163)*(226)*(31)(91)*9*
Share repurchases0*———(0)*———0*———
Net cash from financing activities6*(1)8*(101)*6*315*4*5*(2)9*(1)*
Net change in cash67*5665*(8)*44*5246*(101)*(134)*54(36)*49*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Penumbra25441042*39.4M 10-QSep 30, 2026
Align Technology1,1031,056193*71.0M 10-QJun 30, 2026
Medline2,3277,685715*not reported 10-QJun 27, 2026
Solventum4032,209227*170.2M 10-QJun 30, 2026
Hologic2,1681,048230223.2M 10-QDec 27, 2025
Globus Medical508790210*134.3M 10-QJun 30, 2026
MSA Safety18753682*38.5M 10-QSep 30, 2026
West Pharmaceutical Services464875190*69.7M 10-QSep 30, 2026
GLAUKOS16221139*59.2M 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.